266 related articles for article (PubMed ID: 20386880)
1. Chemical and biological properties of toxic metals and use of chelating agents for the pharmacological treatment of metal poisoning.
Sinicropi MS; Amantea D; Caruso A; Saturnino C
Arch Toxicol; 2010 Jul; 84(7):501-20. PubMed ID: 20386880
[TBL] [Abstract][Full Text] [Related]
2. New developments in therapeutic chelating agents as antidotes for metal poisoning.
Jones MM
Crit Rev Toxicol; 1991; 21(3):209-33. PubMed ID: 2039595
[TBL] [Abstract][Full Text] [Related]
3. Arsenic and lead induced free radical generation and their reversibility following chelation.
Flora SJ; Flora G; Saxena G; Mishra M
Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):26-47. PubMed ID: 17519110
[TBL] [Abstract][Full Text] [Related]
4. [Metal poisoning].
Ferrer A
An Sist Sanit Navar; 2003; 26 Suppl 1():141-53. PubMed ID: 12813482
[TBL] [Abstract][Full Text] [Related]
5. Antagonists for toxic heavy metals.
Jones MM
Proc West Pharmacol Soc; 1984; 27():163-7. PubMed ID: 6494151
[TBL] [Abstract][Full Text] [Related]
6. [Complex-forming drugs used in metal poisoning].
Hornácková M; Placková S
Cesk Farm; 1993 Dec; 42(6):291-3. PubMed ID: 8111864
[TBL] [Abstract][Full Text] [Related]
7. [Therapy of metal poisoning with chelating agents].
Alessio L; Dell'Orto A
Med Lav; 1986; 77(6):639-48. PubMed ID: 3561311
[No Abstract] [Full Text] [Related]
8. Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning.
Kalia K; Flora SJ
J Occup Health; 2005 Jan; 47(1):1-21. PubMed ID: 15703449
[TBL] [Abstract][Full Text] [Related]
9. Predicting metal toxicity in sediments: a critique of current approaches.
Simpson SL; Batley GE
Integr Environ Assess Manag; 2007 Jan; 3(1):18-31. PubMed ID: 17283593
[TBL] [Abstract][Full Text] [Related]
10. [Occupational metal poisoning (author's transl)].
Lachnit V
Wien Klin Wochenschr; 1979 Jun; 91(13):435-41. PubMed ID: 223335
[TBL] [Abstract][Full Text] [Related]
11. Intracellular sites of toxic metals.
Goyer RA
Neurotoxicology; 1983; 4(3):147-56. PubMed ID: 6318166
[TBL] [Abstract][Full Text] [Related]
12. Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity.
Miller AL
Altern Med Rev; 1998 Jun; 3(3):199-207. PubMed ID: 9630737
[TBL] [Abstract][Full Text] [Related]
13. Chelators controlling metal metabolism and toxicity pathways: applications in cancer prevention, diagnosis and treatment.
Kontoghiorghes GJ; Efstathiou A; Ioannou-Loucaides S; Kolnagou A
Hemoglobin; 2008; 32(1-2):217-27. PubMed ID: 18274999
[TBL] [Abstract][Full Text] [Related]
14. Metal-induced developmental toxicity in mammals: a review.
Domingo JL
J Toxicol Environ Health; 1994 Jun; 42(2):123-41. PubMed ID: 8207750
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms triggered by mercury.
Guzzi G; La Porta CA
Toxicology; 2008 Feb; 244(1):1-12. PubMed ID: 18077077
[TBL] [Abstract][Full Text] [Related]
16. Chemical and biological considerations in the treatment of metal intoxications by chelating agents.
Andersen O
Mini Rev Med Chem; 2004 Jan; 4(1):11-21. PubMed ID: 14754439
[TBL] [Abstract][Full Text] [Related]
17. Mercury toxicity. Agency for Toxic Substance and Disease Registry.
Am Fam Physician; 1992 Dec; 46(6):1731-41. PubMed ID: 1456196
[TBL] [Abstract][Full Text] [Related]
18. The antibody-linked chelating polymers for nuclear therapy and diagnostics.
Torchilin VP; Klibanov AL
Crit Rev Ther Drug Carrier Syst; 1991; 7(4):275-308. PubMed ID: 2040018
[TBL] [Abstract][Full Text] [Related]
19. Heavy metals and lysosomes.
Sternlieb I; Goldfischer S
Front Biol; 1976; 45():185-200. PubMed ID: 789127
[TBL] [Abstract][Full Text] [Related]
20. Metal-ion-coordinating properties of the dinucleotide 2'-deoxyguanylyl(5'-->3')-2'-deoxy-5'-guanylate (d(pGpG)3-): isomeric equilibria including macrochelated complexes relevant for nucleic acids.
Knobloch B; Sigel H; Okruszek A; Sigel RK
Chemistry; 2007; 13(6):1804-14. PubMed ID: 17121397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
